NCT00208026View on ClinicalTrials.gov

Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Netherton Syndrome
Interventions
DRUG

Pimecrolimus 1% Cream

Open label single arm

Trial Locations (1)

19104

Children's Hospital of Philadelphia, Philadelphia

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Children's Hospital of Philadelphia

OTHER

NCT00208026 - Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome | Biotech Hunter | Biotech Hunter